Constructing, Deconstructing or Abolishing? Discourses on Masculinities in Violence Against Women Prevention by Stakeholders in Spain
Journal of Interpersonal Violence · 2025
DOI: 10.1177/08862605241265437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interpersonal Violence, 2025. Verfasst von Krizia Nardini und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Alicante, Alicante, Spain. Hauptthemen laut MEDLINE: Masculinity, Gender Equity, Gender-Based Violence, Stakeholder Participation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Ministerio de Ciencia e Innovación, GENDER NET Plus CoFund, Ministerio de Universidades.
Abstract (Originalsprache)
In the field of violence against women (VAW) prevention, one of the current questions at stake is how to address men’s role and masculinities, but it is still an emerging field in Spain. The aim of this study was to analyze the up-to-date discourses on masculinity among stakeholders in the field of VAW prevention and gender equity in Spain. We used a qualitative methodology with semi-structured interviews, conducted between October 2019 and February 2020 in Madrid and Alicante (Spain), with 23 key stakeholders from different areas: in governmental (public health and VAW prevention/intervention, and institutional and policy positioning) and nongovernmental organizations (anti-violence masculinities workers, youth education workers, and feminist and LGBT associations). A discourse analysis was performed with the data collected. Our findings showed that discourses around masculinities among Spanish stakeholders in VAW prevention and gender equity were diverse and presented different layers of critique. Despite a general agreement on the importance of transforming sexist men’s practices toward more gender equitable relations, three main interpretive repertoires were identified: “Constructing positive/new masculinities” discourse, focused on promoting men’s engagement and egalitarian practices; “Deconstructing hegemonic masculinity” discourse, intended to critically identify and question harmful masculinities norms; and “Abolishing gender” discourse, which aims at dismantling masculinity, and gender in general, as a social structure that generates oppression in itself, advocating for its abolition. Those interpretive repertoires were not mutually exclusive and sometimes stakeholders incorporate in their work more than one approach. The study findings shed light on this current emerging and urgent debate and contributes more broadly to the critical assessment of the concepts used and their implications for VAW prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Alicante, Alicante, Spain.
- Health Institute Carlos III, Madrid, Spain.
- CIBER of Epidemiology and Public Health, Madrid, Spain.
ORCID-Profile: Ariadna Cerdán-Torregrosa, Belén Sanz-Barbero, Carmen Vives-Cases
Förderung
- Ministerio de Ciencia e Innovación
- GENDER NET Plus CoFund
- Ministerio de Universidades
Zitieren
APA
Nardini, K., Cerdán-Torregrosa, A., Sanz-Barbero, B., Davó-Blanes, M., & Vives-Cases, C. (2025). Constructing, Deconstructing or Abolishing? Discourses on Masculinities in Violence Against Women Prevention by Stakeholders in Spain. Journal of Interpersonal Violence. https://doi.org/10.1177/08862605241265437
Vancouver
Nardini K, Cerdán-Torregrosa A, Sanz-Barbero B, Davó-Blanes M, Vives-Cases C. Constructing, Deconstructing or Abolishing? Discourses on Masculinities in Violence Against Women Prevention by Stakeholders in Spain. Journal of Interpersonal Violence. 2025. doi:10.1177/08862605241265437
BibTeX
@article{Nardini2025,
author = {Nardini, Krizia and Cerdán-Torregrosa, Ariadna and Sanz-Barbero, Belén and Davó-Blanes, MCarmen and Vives-Cases, Carmen},
title = {Constructing, Deconstructing or Abolishing? Discourses on Masculinities in Violence Against Women Prevention by Stakeholders in Spain},
journal = {Journal of Interpersonal Violence},
year = {2025},
doi = {10.1177/08862605241265437}
}
EUVIMED